Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
18 Years
N/A
Female
Cervical Cancer, Endometrial Cancer, Radiation Toxicity, Sexuality and Reproductive Issues
Trial Information
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
OBJECTIVES:
Primary
- To determine adherence to vaginal dilation therapy after radiotherapy in patients with
early-stage IB grade 2-IIIB cervical cancer or stage IA grade 3-IIB endometrial cancer.
- To identify demographic, medical, and psychosocial factors associated with adherence to
recommendations for vaginal dilation in these patients.
- To describe the sexual, marital, and non-marital dyadic functioning of these patients.
OUTLINE: Patients from the IMPAC registry in Radiation Oncology at the University Hospitals
Case Medical Center, Ireland Cancer Center complete questionnaires online or by mail.
Questionnaires include the Vaginal Dilation Adherence questionnaire, the Sexual
Function-Vaginal Changes Questionnaire, the Dyadic Satisfaction questionnaire, and the
Physician/Nurse Recommendation of Vaginal Dilation questionnaire.
Inclusion Criteria
DISEASE CHARACTERISTICS:
- History of early-stage IB grade 2-IIIB cervical cancer or stage IA grade 3-IIB
endometrial cancer
- Meets the following criteria:
- Received radiotherapy for this disease
- Treated within the last 3 years and followed for at least 6 months
PATIENT CHARACTERISTICS:
- Able to read and understand English
- Currently with or without a sexual partner
- No history of other cancers
- No other potentially life-threatening disease
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Outcome Measure:
Adherence to vaginal dilation therapy after radiotherapy as measured by the Vaginal Dilation Adherence questionnaire
Outcome Time Frame:
one time questionaire
Safety Issue:
No
Principal Investigator
Lois C. Friedman, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
Authority:
United States: Federal Government
Study ID:
CASE5808
NCT ID:
NCT00735514
Start Date:
July 2008
Completion Date:
May 2010
Related Keywords:
- Cervical Cancer
- Endometrial Cancer
- Radiation Toxicity
- Sexuality and Reproductive Issues
- radiation toxicity
- sexuality and reproductive issues
- stage I endometrial carcinoma
- stage II endometrial carcinoma
- stage IB cervical cancer
- stage IIA cervical cancer
- stage IIB cervical cancer
- stage III cervical cancer
- Endometrial Neoplasms
- Sarcoma, Endometrial Stromal
- Uterine Cervical Neoplasms
- Adenoma
- Radiation Injuries
Name | Location |
|---|---|
| Mercy Cancer Center at Mercy Medical Center | Canton, Ohio 44708 |
| Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center | Cleveland, Ohio 44106-5065 |
| Lake/University Ireland Cancer Center | Mentor, Ohio 44060 |
| Geauga Regional Hospital | Chardon, Ohio 44024 |
| Southwest General Health Center | Middleburgh Heights, Ohio 44130 |
| UHHS Chagrin Highlands Medical Center | Orange Villager, Ohio 44122 |
| University Suburban Health Center | South Euclid, Ohio 44121 |
| UHHS Westlake Medical Center | Westlaker, Ohio 44145 |
